Zobrazeno 1 - 5
of 5
pro vyhledávání: '"María del Rosario Custidiano"'
Autor:
María Sol Ruiz, María Belén Sánchez, Simone Bonecker, Carolina Furtado, Daniel Koile, Patricio Yankilevich, Santiago Cranco, María del Rosario Custidiano, Josefina Freitas, Beatriz Moiraghi, Mariel Ana Pérez, Carolina Pavlovsky, Ana Inés Varela, Verónica Ventriglia, Julio César Sánchez Ávalos, Irene Larripa, Ilana Zalcberg, José Mordoh, Peter Valent, Michele Bianchini
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Chronic myeloid leukemia (CML) is a myeloid stem cell neoplasm characterized by an expansion of myeloid progenitor cells and the presence of BCR-ABL1 oncoprotein. Since the introduction of specific BCR-ABL1 tyrosine kinase inhibitors (TKI), overall s
Externí odkaz:
https://doaj.org/article/6c0cae11e6044816982a5967d272e02b
Autor:
Esteban Enrique Elías, María Belén Almejún, Ana Colado, Gregorio Cordini, Maricef Vergara-Rubio, Enrique Podaza, Denise Risnik, María Cabrejo, Horacio Fernández-Grecco, Raimundo Fernando Bezares, María del Rosario Custidiano, Julio César Sánchez-Ávalos, Ángeles Vicente, Gonzalo Martín Garate, Mercedes Borge, Mirta Giordano, Romina Gamberale
Publikováno v:
Haematologica, Vol 103, Iss 10 (2018)
Externí odkaz:
https://doaj.org/article/e0976aeaa4804d988730be7196401a5c
Autor:
María Sol, Ruiz, María Belén, Sánchez, Simone, Bonecker, Carolina, Furtado, Daniel, Koile, Patricio, Yankilevich, Santiago, Cranco, María Del Rosario, Custidiano, Josefina, Freitas, Beatriz, Moiraghi, Mariel Ana, Pérez, Carolina, Pavlovsky, Ana Inés, Varela, Verónica, Ventriglia, Julio César, Sánchez Ávalos, Irene, Larripa, Ilana, Zalcberg, José, Mordoh, Peter, Valent, Michele, Bianchini
Publikováno v:
Frontiers in Pharmacology
Chronic myeloid leukemia (CML) is a myeloid stem cell neoplasm characterized by an expansion of myeloid progenitor cells and the presence of BCR-ABL1 oncoprotein. Since the introduction of specific BCR-ABL1 tyrosine kinase inhibitors (TKI), overall s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cfffa1699defb83ec28250f7272947d6
https://pubmed.ncbi.nlm.nih.gov/33569005
https://pubmed.ncbi.nlm.nih.gov/33569005
Autor:
Valeria J. Sarapura Martinez, Brenda Buonincontro, Chiara Cassarino, Juliana Bernatowiez, Ana Colado, Gregorio Cordini, Maria del Rosario Custidiano, Carolina Mahuad, Miguel A. Pavlovsky, Raimundo F. Bezares, Nicolás O. Favale, Mónica Vermeulen, Mercedes Borge, Mirta Giordano, Romina Gamberale
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The treatment of chronic lymphocytic leukemia (CLL) patients with venetoclax-based regimens has demonstrated efficacy and a safety profile, but the emergence of resistant cells and disease progression is a current complication. Therapeutic target of
Externí odkaz:
https://doaj.org/article/4784f55067b54e2195084088e6822aa4
Autor:
Alexia Vereertbrugghen, Ana Colado, Ernesto Gargiulo, Raimundo Fernando Bezares, Horacio Fernández Grecco, Gregorio Cordini, Maria del Rosario Custidiano, Jean-Hugues François, Guy Berchem, Mercedes Borge, Jerome Paggetti, Etienne Moussay, Romina Gamberale, Mirta Giordano, Pablo Elías Morande
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Current standard treatment of patients with hairy cell leukemia (HCL), a chronic B-cell neoplasia of low incidence that affects the elderly, is based on the administration of purine analogs such as cladribine. This chemotherapy approach shows satisfa
Externí odkaz:
https://doaj.org/article/8023bcc1246e4bd080357aa16d54a4d1